Opko Health Inc
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, m… Read more
Opko Health Inc (OPK) - Total Assets
Latest total assets as of September 2025: $2.00 Billion USD
Based on the latest financial reports, Opko Health Inc (OPK) holds total assets worth $2.00 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Opko Health Inc - Total Assets Trend (1995–2024)
This chart illustrates how Opko Health Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Opko Health Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Opko Health Inc's total assets of $2.00 Billion consist of 30.1% current assets and 69.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 19.6% |
| Accounts Receivable | $152.05 Million | 6.9% |
| Inventory | $56.80 Million | 2.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $811.61 Million | 36.9% |
| Goodwill | $529.25 Million | 24.1% |
Asset Composition Trend (1995–2024)
This chart illustrates how Opko Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Opko Health Inc's current assets represent 30.1% of total assets in 2024, a decrease from 83.1% in 1995.
- Cash Position: Cash and equivalents constituted 19.6% of total assets in 2024, down from 83.1% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 13.0% in 1995.
- Asset Diversification: The largest asset category is intangible assets at 36.9% of total assets.
Opko Health Inc Competitors by Total Assets
Key competitors of Opko Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Opko Health Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Opko Health Inc generates 0.32x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Opko Health Inc is currently not profitable relative to its asset base.
Opko Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.70 | 2.97 | 1.39 |
| Quick Ratio | 3.32 | 2.69 | 1.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $457.81 Million | $ 417.98 Million | $ 147.70 Million |
Opko Health Inc - Advanced Valuation Insights
This section examines the relationship between Opko Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.71 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | 9.4% |
| Total Assets | $2.20 Billion |
| Market Capitalization | $414.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values Opko Health Inc's assets below their book value (0.19 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Opko Health Inc's assets grew by 9.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Opko Health Inc (1995–2024)
The table below shows the annual total assets of Opko Health Inc from 1995 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.20 Billion | +9.37% |
| 2023-12-31 | $2.01 Billion | -7.18% |
| 2022-12-31 | $2.17 Billion | -9.69% |
| 2021-12-31 | $2.40 Billion | -2.97% |
| 2020-12-31 | $2.47 Billion | +7.09% |
| 2019-12-31 | $2.31 Billion | -5.79% |
| 2018-12-31 | $2.45 Billion | -5.36% |
| 2017-12-31 | $2.59 Billion | -6.38% |
| 2016-12-31 | $2.77 Billion | -1.18% |
| 2015-12-31 | $2.80 Billion | +120.84% |
| 2014-12-31 | $1.27 Billion | -8.90% |
| 2013-12-31 | $1.39 Billion | +380.11% |
| 2012-12-31 | $289.83 Million | +26.29% |
| 2011-12-31 | $229.49 Million | +194.80% |
| 2010-12-31 | $77.85 Million | -10.96% |
| 2009-12-31 | $87.43 Million | +301.72% |
| 2008-12-31 | $21.76 Million | -45.00% |
| 2007-12-31 | $39.57 Million | +352.10% |
| 2006-12-31 | $8.75 Million | -2.76% |
| 2005-12-31 | $9.00 Million | -10.63% |
| 2004-12-31 | $10.07 Million | -11.21% |
| 2003-12-31 | $11.34 Million | -35.24% |
| 2002-12-31 | $17.52 Million | -36.60% |
| 2001-12-31 | $27.62 Million | -26.09% |
| 2000-12-31 | $37.38 Million | +732.29% |
| 1999-12-31 | $4.49 Million | -41.68% |
| 1998-12-31 | $7.70 Million | +175.00% |
| 1997-12-31 | $2.80 Million | -28.21% |
| 1996-12-31 | $3.90 Million | -40.00% |
| 1995-12-31 | $6.50 Million | -- |